32.1 C
Vientiane
Thursday, July 3, 2025
spot_img
Home Blog Page 388

Singapore cybersecurity companies pioneer AI and quantum computing solutions to combat global threats


SINGAPORE – Media OutReach Newswire – 23 April 2025 – The global cybersecurity landscape is rapidly evolving, with the annual cost of cybercrime projected to reach US$10.5 trillion by 2025, up from US$8 trillion in 20231. This sharp rise underscores the urgent need to address cyber risks, as malicious actors continue to exploit vulnerabilities across industries worldwide. In response, Singapore is accelerating the development of cybersecurity innovations, not only to protect its own infrastructure but also to address emerging risks globally.

Three homegrown companies, cloudsineAI, Cyber Sierra and pQCee, are leading this effort with specialized solutions to tackle some of the biggest threats today like GenAI-driven attacks2 and quantum decryption risks. These challenges remain difficult for traditional cybersecurity solutions to address. With 70 to 80 percent of existing tools being one-size-fits-all3, critical gaps in protection remain, leaving organizations vulnerable to increasingly sophisticated threats.

These Singapore-based innovators are supported by the US$15 million CyberSG Talent, Innovation, and Growth Collaboration Center, a joint initiative between the National University of Singapore (NUS) and the Cyber Security Agency of Singapore (CSA). By targeting high-impact, niche vulnerabilities, they help organizations worldwide stay ahead of emerging threats while ensuring the safe use of new technologies.

“Singapore’s CyberSG Talent, Innovation and Growth Collaboration Center, in conjunction with our National Cybersecurity R&D Program, aims to drive key innovations in the global cybersecurity landscape. We support companies developing advanced digital infrastructure protection, strengthening our nation’s defenses while empowering collaborative global efforts against a rising tide of cyberattacks, marked by a 30 percent increase in 2024,” said Associate Professor Benjamin Tee, Vice President (Ecosystem Building), NUS Enterprise.

cloudsineAI: Blocking malicious content in GenAI applications

As GenAI adoption rapidly increases, so do the risks they pose, from prompt injection to sensitive data leakage. According to the Big Four accounting firm Deloitte, it is expected that GenAI could enable fraud losses to reach $40 billion in the US by 20274. To address these emerging threats, cloudsineAI has launched a new GenAI firewall, built specifically to protect mission-critical GenAI applications. Unlike traditional firewalls that protect against standard network or web application threats, this solution is powered by its unique ShieldPrompt™ multi-layered defense that actively scans both user inputs and AI-generated outputs to prevent the injection and block harmful or sensitive content.

The GenAI firewall also complements any AI guardrails to provide an updated threat vector database, contextualized security controls and integration with other security tools such as SIEMs. This innovation ensures that organizations can safely and securely innovate with GenAI while mitigating advanced cyber threats.

Cyber Sierra: The AI platform with agentic infrastructure for comprehensive compliance and protection

Cyber Sierra’s AI platform and agentic infrastructure enables complete protection and compliance. By integrating Cyber Governance, Risk Management, and Compliance (GRC) as well as Continuous Controls Monitoring (CCM), the architecture is built to meet the evolving demands of security and compliance teams. By harnessing intelligent automation and AI agents into human teams, Cyber Sierra is transforming how organizations detect risks, accelerate response times, while maintaining comprehensive compliance.

Cyber Sierra is also the first cybersecurity company in Southeast Asia to be recognized as a Sample Vendor in two key categories, Cyber GRC and CCM, in the Gartner® Hype Cycle for Cyber Risk Management 2024.

pQCee: Futureproofing data against quantum threats

SafeQuard by pQCee is a lightweight security tool that protects documents from the growing risks posed by quantum computers. Hackers are already stealing encrypted data today, with plans to decrypt it once powerful quantum computers become available. As this technology advances, sensitive documents stored now could be compromised in the future, making quantum-safe encryption a critical need today.

Fully compliant with security standards set by the National Institute of Standards and Technology, SafeQuard safeguards the long-term confidentiality of high-value documents, protecting sensitive personal data and proprietary business information well into the quantum future.

Debuting Singapore’s cybersecurity solutions at the RSA Conference 2025

These three cybersecurity companies (see Annex A for quotes), along with three others from the CyberSG Talent, Innovation, and Growth Collaboration Center (The Center), will showcase their solutions at Singapore’s first national pavilion at the RSA Conference 2025 held from 28 April to 1 May 2025 at the Moscone Center in San Francisco (see Annex B for more information on the companies).

Organized by the Center and SGTech, the Singapore Pavilion aims to position the country as both a leading hub for cybersecurity innovation and a strategic gateway to Asia’s rapidly expanding US$7.5 billion digital economy. For more information on the Centre, please visit tig.cybersg.sg.

Hashtag: #cybersecurity #singaporecybersme #CybersgTIG #nusenterprise #NUS

The issuer is solely responsible for the content of this announcement.

CyberSG Talent, Innovation and Growth Collaboration Centre

The CyberSG Talent, Innovation and Growth Collaboration Centre, established by the Cyber Security Agency of Singapore (CSA) in partnership with the National University of Singapore (NUS), will play a key role in achieving a comprehensive approach to ecosystem development which consolidates and enhances CSA’s existing talent and innovation initiatives. The Centre will enable synergies between cybersecurity talent, innovation and growth industry, by serving as a national node to integrate and create relevant programmes for industry and talent development. It will help build a vibrant cybersecurity ecosystem by bring together industry, academia, individual and government stakeholders to leverage the opportunities posed by digitalisation.

For more information on the Centre, please visit

National University of Singapore (NUS)

The National University of Singapore (NUS) is Singapore’s flagship university, which offers a global approach to education, research and entrepreneurship, with a focus on Asian perspectives and expertise. We have 16 colleges, faculties and schools across three campuses in Singapore, with more than 40,000 students from 100 countries enriching our vibrant and diverse campus community. We have also established more than 20 NUS Overseas Colleges entrepreneurial hubs around the world.

Our multidisciplinary and real-world approach to education, research and entrepreneurship enables us to work closely with industry, governments and academia to address crucial and complex issues relevant to Asia and the world. Researchers in our faculties, research centres of excellence, corporate labs and more than 30 university-level research institutes focus on themes that include energy; environmental and urban sustainability; treatment and prevention of diseases; active ageing; advanced materials; risk management and resilience of financial systems; Asian studies; and Smart Nation capabilities such as artificial intelligence, data science, operations research and cybersecurity.

For more information on NUS, please visit .

NUS Enterprise

NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS), plays a pivotal role in advancing innovation and entrepreneurship at NUS and beyond. We actively promote entrepreneurship and cultivate global mind-sets and talents through the synergies of experiential learning, active industry partnerships, holistic entrepreneurship support and catalytic entrepreneurship outreach. Our initiatives and global connections support a range of entrepreneurial journeys and foster ecosystem building in new markets. We provide expertise and connections to create successful spin-offs and translate innovations into the marketplace through industry collaboration. These initiatives augment and complement the University’s academic programmes and act as a unique bridge to industries well beyond Singapore’s shores.

For more information on NUS Enterprise, please visit .

THE KORE IMPACT SET TO INTRODUCE INNOVATIVE KOREAN “GONGGU” CONCEPT TO US CREATORS AT EXCLUSIVE LA EVENT

BEVERLY HILLS, Calif., April 23, 2025 /PRNewswire/ — The Kore Impact Inc., a pioneering marketing company headquartered in Beverly Hills, is set to revolutionize the US e-commerce landscape with the introduction of “gonggu,” an innovative Korean group purchasing concept. The company will host an exclusive event for 100 creators in the Los Angeles area to showcase this unique marketing approach and to preview Korean products soon to be available in the American market.

The invite-only event will offer influential content creators a first look at The Kore Impact’s groundbreaking platform, Keverything, scheduled to launch on May 24th, 2025.This platform aims to connect US consumers with a portfolio of Korean products through a strategic network of influencer partnerships.

At the heart of The Kore Impact is a bold and visionary mission: to spark a cultural movement through commerce. Keverything isn’t just a shopping platform—it’s a curated gateway into the soul of Korea. From the electrifying energy of K-pop, the storytelling magic of K-dramas and K-movies, to the bold creativity of K-Art. Let’s not forget about the advanced technology of K-Skincare, the world-renowned excellence of K-Medical and K-Plastic Surgery, and the unforgettable experiences of K-Tourism—every offering being designed to inspire, connect, and elevate.

For Gen Z and Millennials in the U.S., this is more than a transaction—it’s an invitation to explore identity, culture, and innovation in one immersive experience. It’s where style meets substance, culture meets commerce, and passion meets greater possibilities.

Gonggu represents a transformative approach to group purchasing that maximizes reach while minimizing costs for both brands and consumers,” says Claudia Choi, CEO of The Kore Impact. “By bringing this concept to the US market, we’re creating an exciting opportunity for American creators to introduce their audiences to high-quality Korean products through a unique, community-driven shopping experience.”

The Kore Impact is actively building a global network of over 500,000 influencers who will collaborate through the Keverything platform to promote limited-time product campaigns using the gonggu model. This strategy has proven highly successful in the Korean market and is poised to capitalize on the growing popularity of K-culture in the United States.

The company’s goal is clear: to promote the Korean Wave (“Hallyu”) in the US and spark genuine connections between Korean brands and American consumers through the power of trusted creator voices. The upcoming LA event marks a major milestone in positioning gonggu as a revolutionary force in American e-commerce—and The Kore Impact as the bridge between the two cultures.

thekoreimpact.com

About The Kore Impact Inc.
The Kore Impact Inc. is an online marketing company based in Beverly Hills, California, dedicated to connecting Korean brands with US creators. Through the Keverything app, which is launching on May 24, 2025, the company introduces American consumers to premium Korean products via trusted influencer partnerships. With a mission to elevate K-culture and spark cross-cultural innovation, The Kore Impact is pioneering a new wave of commerce, driven by creativity, authenticity, and global connection.

 

DSC® Celebrates Earth Day With Tree Planting Participated by Nearly 1,000 Global Employees and Sustainable Material Innovation

PORTLAND, Ore., April 23, 2025 /PRNewswire/ — DSC®, a global leader in performance foam manufacturing, celebrates Earth Day from the ground up with its strong commitment to sustainable innovation,  waste and carbon emissions reduction, and reforestation efforts that contribute to a greener future. Today, DSC® launches another year of environmental stewardship with its annual tree planting initiative, nearly 1,000 employees around the globe are participating in this event, including in Vietnam, Indonesia, China, and U.S.

DSC® launches another year of environmental stewardship with its annual tree planting initiative. Nearly 1,000 DSC employees in Vietnam, Indonesia, China, and the U.S. are participating in the tree planting event.
DSC® launches another year of environmental stewardship with its annual tree planting initiative. Nearly 1,000 DSC employees in Vietnam, Indonesia, China, and the U.S. are participating in the tree planting event.

The initiative is part of DSC’s sustainability roadmap, Run the Relay – an ambitious plan powered by a zero-carbon, zero-waste mission. The long-term vision centers on reducing carbon emissions, cutting down waste, transitioning to renewable energy, fostering innovation, and employee engagement.

“We celebrate Earth Day today, but DSC® is committed to reducing our impact on the environment every day,” said Fennie Wei, COO of DSC®. “With sustainable materials and designing for a circular economy, we’re creating high-performance insoles that support a low-carbon future for both the planet and the people who wear them.”

Beyond its ongoing commitment to environmental sustainability, DSC® continues to lead the industry in material innovation, introducing bio-based alternatives that reduce dependency on fossil fuels. One of its most notable breakthroughs, DREAMCELL® XPRESSO, is a foam made with spent coffee grounds (SCG). This innovation not only enhances comfort and durability but also helps reduce landfill waste and greenhouse gas emissions. 

Another breakthrough supporting DSC®‘s vision of closed-loop manufacturing is DREAMCELL® ZERO – an insole made with 100% reused foam waste designed for comfort. By transforming foam waste into new products, DSC® takes a decisive step toward a circular economy in the footwear supply chain, closing the loop on waste, and creating a sustainable cycle of production and consumption.

Alongside its use of recycled or bio-based content, DSC® also pioneered the use of supercritical fluid foaming technology in large-scale insole production with its DURAPONTEX® N-Series. This method eliminates the use of harmful chemical blowing agents, and instead infusing nitrogen or carbon dioxide to create an innovative, high-performance foam. It creates ultra-lightweight insoles with evenly spaced microscopic bubbles and air pockets that offer superior cushioning and unmatched resilience.

For 80 years since its founding in 1945, Dahsheng Chemical (DSC®) has been a leader in foam innovation for the sports industries. Known for its premium comfort and performance foam DURAPONTEX® and DREAMCELL®, DSC® partners with top brands and footwear manufacturers worldwide. By advancing innovation and pushing the limits of foam manufacturing, DSC® is dedicated to creating eco-friendly and advanced foam solutions that set new standards in the industry.

Visit www.dahsheng.com to learn more about Dahsheng Chemical (DSC®) and its commitment to sustainability and eco-innovation.

Media Contact:
Erin Patterson
t: +1-323-422-0274
e: erin.patterson@writetheskycomms.com

 

Trip.com Group Witnesses Double-digit Cross-border Growth for May Labour Day Holiday

  • Trips to two or more cities increase by 60% compared to last year
  • Triple-digit growth in alternative stays – popular among travellers in South Korea, Hong Kong SAR and Thailand
  • Strong cross-border travel from China, Japan, South Korea and Vietnam

SINGAPORE, April 23, 2025 /PRNewswire/ — The Labour Day holiday continues to be a peak travel period for many destinations in the Asia-Pacific region, with holiday-makers from Japan, Vietnam and the Chinese mainland seizing longer holiday public breaks for domestic or overseas getaways. Meanwhile, travellers from South Korea, Hong Kong SAR, Singapore and Thailand can enjoy a long weekend by combining the public holiday with annual leave.


Asia Tops the Charts, with Evolving Taste for Nature-based Alternative Accommodation

According to Trip.com Group’s latest booking data, Asia-Pacific travellers are exhibiting a stronger interest in travelling closer to home this Labour Day holiday—be it domestically or regionally. The top five cross-border destinations include Japan, China, South Korea, Thailand and Malaysia. Overall, Asia-Pacific key markets have seen close to triple-digit growth for domestic travel, and strong double-digit growth in cross-border travel this May holiday season.


Accommodation preferences are also evolving. Travellers are expanding beyond traditional hotels, leading to a surge in demand for apartments, villas, and inns. Alternative stays have seen triple-digit booking growth in markets such as South Korea, Thailand, and Hong Kong SAR.

Bookings are increasingly concentrated in destinations surrounded by nature—scenic lakes, mountains, national parks, and beaches are driving interest. Japan has emerged as a favourite for these types of stays, thanks to its hot springs, views of Mt. Fuji, and access to Hakone National Park.

Travellers are increasingly turning to coastal locations for villa stays, especially where sea views and beach access are front and centre. This shift is particularly noticeable among Chinese mainland, Japanese, and South Korean travellers. Bali, for example, is experiencing a notable uptick in villa bookings.


In line with this shift, searches for nature-based breaks and Instagrammable destinations have recorded triple-digit growth, highlighting a growing desire for aesthetically appealing escapes that offer tranquillity and a deeper connection to the natural environment.

Regional Travel Takes Off: China and Japan Lead the Way, South Korea and Vietnam Travel Growing

The Labour Day holiday remains a powerful driver of cross-border travel across Asia, particularly in China, with a five-day holiday from 1-5 May, while Japan celebrates its ‘Golden Week’ holiday from 29 April to 6 May. Trip.com Group data shows strong cross-border travel from China and Japan compared to 2024.

Top regional destinations for Chinese travellers include Japan, South Korea, Malaysia, Thailand, and Singapore, while Japanese travellers are flocking to South Korea, Thailand, Vietnam, the Philippines, and the United States.

Notably, both South Korea and Vietnam have the opportunity to holiday for longer. Vietnam will celebrate a five-day holiday from Wednesday, 30 April to Sunday, 4 May, for Reunification Day and International Workers’ Day, while South Korean travellers, on the other hand, can utilise two days of annual leave to get six days off between 1 May and 6 May.

As such, booking data shows a substantial increase in domestic and cross-border bookings for both markets. Vietnam is witnessing an increase of over 190% in domestic bookings, with cross-border bookings exceeding 150%.  The trend is similar for South Korea, with domestic bookings surging by nearly 190% and cross-border travel up by over 150%, indicating the impact of this extended May holiday.

A Rise in Multi-City Destinations and Flights Over Six Hours

Making the most of the holidays is an ever-appealing trend across Asia, reflected by multi-destination stays. Bookings for trips to two or more cities have increased by 60% compared to last year.


Asia-Pacific multi-city itineraries are designed around clusters of closely connected cities within a single country. Travellers from Malaysia, for instance, are choosing to explore both Chengdu and Chongqing during trips to China, while visitors from Hong Kong SAR are pairing visits to Kyoto and Osaka in Japan. Chinese tourists are also embracing this trend, favouring Japan and commonly combining Osaka and Tokyo into one seamless journey.

Flights over six hours are the fastest-growing flight segment, compared to last year. Long-haul journeys among South Korean travellers are reaching triple-digit growth, and Chinese, Japanese, and Vietnamese travellers are seeing strong double-digit increases.

As these long-haul trips rise in popularity, travellers are also opting to visit more than one destination per journey. Japanese tourists are opting for a blend of London and Barcelona, combining British heritage with Mediterranean vibrancy. Chinese travellers are exploring London and Edinburgh, capturing a north-south sweep of the UK. At the same time, South Korean visitors frequently pair London with Paris for a classic European twin-city experience.

Engaging Experiences and Gourmet Stops

Travellers continue to flock to Asia’s most dynamic urban hubs, with Tokyo, Osaka, Seoul, Hong Kong SAR, and Bangkok emerging as the top cities. The surge reflects a consistent appetite for destinations that seamlessly blend vibrant street life, deep-rooted traditions, and must-try food experiences. Food-related searches have seen a notable uptick across the region, with almost 20% growth in culinary searches. Popular cuisines and local delicacies are increasingly influencing destination choice. Japanese cuisine is seeing the highest search volume for food in Osaka and Tokyo, representing the local food scene of these two popular cities.


At the same time, event tourism is rising. Concert tour bookings show double-digit growth for the May holiday. Notably, Japanese tourists are attending domestic music events, such as concerts by the Korean boy group Tomorrow X Together. Chinese mainland consumers favour events in South Korea, like HIPHOPPLAYA FESTIVAL 2025 and domestic events, such as the Beijing Strawberry Festival. Travellers departing from Hong Kong SAR are keen to catch homegrown talent Eason Chan, at his FEAR and DREAMS World Tour in Tokyo—all signalling travellers’ increasing interest in combining cultural experiences with their travel plans.

The 2025 Labour Day holiday illustrates the growing complexity and choice being embraced by modern travellers—from nature-rich retreats and food-led journeys to long-haul, multi-stop adventures—highlighting a new era of discovery in global travel.

About Trip.com Group

Trip.com Group is a leading global travel service provider comprising of Trip.com, Ctrip, Skyscanner, and Qunar. Across its platforms, Trip.com Group helps travellers around the world make informed and cost-effective bookings for travel products and services and enables partners to connect their offerings with users through the aggregation of comprehensive travel-related content and resources, and an advanced transaction platform consisting of apps, websites and 24/7 customer service centres. Founded in 1999 and listed on NASDAQ in 2003 and HKEX in 2021, Trip.com Group has become one of the best-known travel groups in the world, with the mission “to pursue the perfect trip for a better world”. Find out more about Trip.com Group here: group.trip.com.

Follow us on: X, Facebook, LinkedIn, and YouTube.

Pulxion and Medtronic Partner to Advance Innovative Health Solutions

TAIPEI, April 23, 2025 /PRNewswire/ — According to statistics published by the World Health Organization (WHO) in 2025, cardiovascular diseases (CVDs) are the leading cause of death globally, claiming approximately 18 million lives annually and accounting for 32% of all deaths worldwide. This highlights the crucial importance of early detection and timely management of CVDs.

Pulxion Medical Technology is dedicated to developing innovative solutions to address global health challenges, with focus on the prevention and management of cardiovascular diseases. The company aims to integrate advanced medical technologies, particularly in response to the increasing prevalence of younger patients with CVDs, such as stroke and coronary artery disease. By enabling early and rapid screening, this approach supports proactive prevention and timely intervention.

Professor Herbert Hsiao, founder of Pulxion and an esteemed professor at National Taiwan University, remarked, “Pulxion was founded with the vision of transforming traditional disease screening methods through innovative technologies, making health management simpler and more accessible. Our core product integrates advanced AI-powered video motion analysis technology to provide rapid and non-invasive disease risk assessments tailored to the needs of modern preventive healthcare, allowing more people to benefit from the convenience and efficiency of early screening.”

Joy Chen, CEO of Pulxion, stated, “Pulxion continuously seeks opportunities to promote innovative solutions. Recently, we signed a Memorandum of Understanding (MOU) with Medtronic, a global leader in medical devices, establishing a strategic partnership. We plan to jointly promote Pulxion’s core product in Taiwan, Hong Kong, and Macau, accelerating the adoption and application of early screening technologies. In Taiwan, Pulxion has initiated the pivotal clinical trials of our core product in major medical centers to obtain regulatory approval from the Taiwan Food and Drug Administration (TFDA).”

Pulxion Medical Technology has taken a significant step in advancing early screening for cardiovascular diseases, further strengthening its momentum toward realizing its healthcare vision of “prevention-first.” Moving forward, Pulxion will continue collaborating with industry leaders to drive the adoption of innovative medical technologies, create greater value for the industry, and contribute to global health improvement.

Rapid Screening for CVDs Risk
Rapid Screening for CVDs Risk

Sources:

  1.  World Health Organization (https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1)
  2.  Ministry of Health and Welfare (https://www.mohw.gov.tw/cp-4634-52471-1.html)
  3. Health Promotion Administration, Ministry of Health and Welfare (https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=4809&pid=18445)

Cohesity Automation Provides Faster, More Comprehensive Cyber Incident Response

Cohesity RecoveryAgent’s AI-powered Orchestration Makes Cyber Response and Recovery Easy so Customers Can Recover From Incidents Faster and With More Confidence 

SINGAPORE, April 23, 2025 /PRNewswire/ — Cohesity, the leader in AI-powered data security, today announced Cohesity RecoveryAgent, a new AI-powered cyber orchestration solution for Cohesity NetBackup and DataProtect customers. RecoveryAgent automates cyber recovery preparation, testing, compliance, and response, enabling customers to recover from cyber incidents faster. It offers intelligent, customizable recovery blueprints and enables rigorous testing of recovery processes in a non-production environment, giving customers more confidence in their ability to respond to proliferating cyberattacks.

Simplifying Cyber Recovery Through Automation and Intelligence
Modern IT environments are complex, comprising physical, virtual, and cloud-based systems. Responding to cyberattacks requires organizations to navigate this complexity while ensuring data integrity, availability, and regulatory compliance. RecoveryAgent addresses these challenges by generating customizable blueprints that automate recovery workflows, making cyber recovery response more efficient and adaptable.

With these customizable blueprints, organizations can better prepare for cyber incidents before they happen. RecoveryAgent’s intuitive UI allows teams to easily build recovery plans with scripted workflows that automatically integrate critical steps for incident response, such as threat hunting, malware scanning, and instant data restores. Users can rehearse recoveries to prove the blueprint will effectively recover their data in a non-production environment without impacting production applications. This frequent testing helps ensure readiness for real-world incidents.

RecoveryAgent’s Agentic AI capabilities allow recovery teams to:

  • Rapidly and easily create and edit recovery blueprints with AI assistance for automated testing of cyber impact or disaster recovery
  • Manage granular recovery across multiple domains in complex hybrid environments, including on-premises, cloud, PaaS, and containers
  • Speed up forensic investigations through automated threat scanning using native tools and best-in-class threat intelligence from Data Security Alliance partners
  • Have more confidence in a clean incident recovery with Agentic AI-powered intelligent recovery point recommendations and blast radius analysis of infected files across domains
  • Understand the real-world recovery times and how they align with the business SLAs
  • Ensure and demonstrate compliance with regulatory and business drivers by implementing standard recovery practices

“Every moment matters to customers experiencing a cyber incident. Having a comprehensive and thoroughly tested incident response plan can be the difference between minimal disruption and massive impact,” said Vasu Murthy, Chief Product Officer, Cohesity. “By simplifying and automating every step of the complex cyber recovery process, RecoveryAgent helps customers boost resilience and respond faster with more confidence to cyber incidents. The world’s largest organizations trust Cohesity because we understand the impact of cyber incidents and consistently offer new solutions like RecoveryAgent to help our customers be more confident in their cyber readiness and recovery.”

Seamless Integration for Enhanced Cyber Resilience
RecoveryAgent automates time-consuming and manual tasks such as vulnerability scanning, malware scanning, and data classification into a structured blueprint. It can also automate forensics investigation, configuration hardening, and patching when orchestrated on virtual machines that are recovered within the solution. These capabilities are powered by Cohesity’s Data Security Alliance, which integrates with leading security vendors to help security teams become more agile and productive. Additionally, RecoveryAgent enhances Cohesity’s existing clean room solution, making activation faster and more intuitive.  

“AntemetA has a complex technology infrastructure, and as a result, we need solutions developed with extensive field experience to enable us to be as effective as possible, especially as we are exposed to increasing amount of cyber risks,” said Stéphane Colin, CTO, AntemetA. “This is only possible with trusted partners who take time to understand our unique complexity and work with us to ensure our data can be recovered with confidence and our services guarantee the highest level of resilience, whatever cyber challenges we face. We have a longstanding partnership with Cohesity because it continues to develop solutions like RecoveryAgent, which help us deliver more relevant and effective services. That, in turn, has earned us an equally long-lasting trust from our customers.”

RecoveryAgent is the first new offering to emerge from the joint development efforts of Cohesity and Veritas since the companies came together in December. By combining the capabilities of NetBackup Recovery Blueprints and Recommended Recovery Points with AI-powered intelligence and innovation native to DataProtect, RecoveryAgent is an example of the rapid innovation enabled by integrating both companies’ technology. It also highlights Cohesity’s commitment to simplifying user experiences and enhancing customer confidence in cyber resilience strategies.

RecoveryAgent is currently available to select customers in Tech Preview and is expected to be generally available for NetBackup and DataProtect customers in the second half of the calendar year 2025.

For more information about Cohesity RecoveryAgent and how it can support your organization’s cybersecurity needs, watch our video. And for more insights on breach response and how to strengthen your organization’s resilience, watch our conversation.    

About Cohesity

Cohesity is the leader in AI-powered data security. Over 13,600 enterprise customers, including over 85 of the Fortune 100 and nearly 70% of the Global 500, rely on Cohesity to strengthen their resilience while providing Gen AI insights into their vast amounts of data. Formed from the combination of Cohesity with Veritas’ enterprise data protection business, the company’s solutions secure and protect data on-premises, in the cloud, and at the edge. Backed by NVIDIA, IBM, HPE, Cisco, AWS, Google Cloud, and others, Cohesity is headquartered in Santa Clara, CA, with offices around the globe. To learn more, follow Cohesity on LinkedIn, X, and Facebook.

Eyebright Medical Published its 2024 Environmental, Social and Governance Report

Commitment to Sustainable Development, Social Responsibility, and Corporate Governance

HONG KONG, April 23, 2025 /PRNewswire/ — Eyebright Medical Technology (Beijing) Co., Ltd. (“Eyebright Medical“, the “Company“, Stock Code: 688050.SH, together with its subsidiaries collectively known as the “Group“) is proud to announce that the Company has published its 2024 Environmental, Social and Governance Report.

Continuous Optimization of Core Profitability

During 2024, the Company reported revenue of RMB 1,410.02 million, a 48.24% increase compared to the prior year. Net profit attributable to shareholders was RMB 388.40 million, up 27.77% from the previous year. Excluding non-recurring items, net income reached RMB 390.08 million, reflecting a 35.08% increase. Basic earnings per share were RMB 2.05, highlighting Eyebright Medical’s strong performance and commitment to shareholder value.

Establishing a Cohesive Environmental Protection System with Diverse Energy-Saving Measures

Eyebright Medical prioritizes environmental protection by establishing a cohesive system that optimizes processes and upgrades facilities to meet strict standards, thereby enhancing governance.

In March 2025, the Company achieved ISO 14001 certification and actively promotes an energy management system while implementing various energy-saving initiatives, leading to ISO 50001 certification in February 2025. Certain production bases have also installed photovoltaic systems to harness solar energy, reducing reliance on non-renewable sources.

The “HiGenie” brand launched an “Empty Tube Recycling” program, encouraging sustainable consumption with no-threshold coupons for exchanging empty tubes. Eyebright’s commitment to sustainability is recognized by its inclusion in Beijing’s directory of water-saving enterprises for its innovations in water-saving technology and efficient resource utilization.

Advancing Global Collaboration and Employee Development While Upholding Social Responsibility and Health Standards

Eyebright Medical is dedicated to creating a global academic platform that integrates medical research with practice while supporting employee career development. During the Reporting Period, the company hosted 2 international exhibitions, 20 national conferences, and 70 regional meetings, attracting 2,783 online participants and 29,088 views. The Company has revised 2 state standards and 5 others, partnering with 5 universities and donating over RMB 1.2 million in materials to benefit 1,400 students.

Since 2022, Eyebright Medical has collaborated with 15 universities, contributing over RMB 4.5 million, providing 500 hours of training, and empowering over 2,500 students and 10,000 vision care professionals. The company established training bases at China Eye Valley, Tianjin Eye Hospital Vision Center, and its Beijing headquarters, conducting five sessions with 118 hours of instruction for over 200 participants. Its workforce comprises 57% female and 43% male employees, along with a balanced senior executive team.

To promote work-life balance, Eyebright Medical organizes initiatives like World Book Day, Sports Day, and outdoor activities. Prioritizing employee health, it achieved ISO 45001 certification in March 2025. The company is committed to international aid, grassroots healthcare, philanthropy, and scientific outreach, emphasizing its social responsibility and sustainable development goals.

Enhancing Governance and Transparency While Recognized for Shareholder Value and Quality Initiatives

Eyebright Medical is committed to optimizing governance by standardizing controls, protecting shareholder rights, and enhancing information security. The company has achieved an A-level disclosure rating from the Shanghai Exchange for 2 consecutive years, reflecting its dedication to corporate governance excellence.

During 2024, Eyebright Medical held 7 board meetings, approving 47 proposals, and 8 board committee meetings with 40 proposals approved. Additionally, it conducted 5 supervisory committee meetings and 1 shareholder meeting, leading to 11 proposals approved.

To improve quality and efficiency, Eyebright Medical launched its 2024 “Quality Improvement and Efficiency Enhancement for Returns” action plan, safeguarding investor rights through a share buyback of RMB 20.04 million and executive buy-ins of RMB 3.44 million. In March 2025, the Shanghai Stock Exchange recognized the Company as a model for shareholder value creation.

About Eyebright Medical

Eyebright Meical Technology (Beijing) Ltd (“Eyebright Medical”; SH Stock Code: 688050.SH) is a National High-tech Enterprise and state-level technologically advanced ‘little giant’ enterprises, located in Zhongguancun Science and Technology Park, Beijing, China.

The Company is an innovation-driven ophthalmic medical device manufacturer. Its balanced product portfolio spans three major areas of the ophthalmic field: cataract surgery, myopia management, as well as consumer vision care. Anchored by its three core product categories – intraocular lenses, orthokeratology lenses, and soft contact lenses – the company has strategically expanded its product pipeline to cover the full life cycle of eye health solutions. Eyebright Medical is striding into a world-leading medical enterprise on behalf of China’s ‘intelligent manufacturing’ power.

For more information about Eyebright Medical, please visit the official website of the Group: http://www.ebmedical.com/en/

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg

TOKYO, April 23, 2025 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 679 million (USD 4.5 million1) for the development of diagnostics for tuberculosis, in addition to an investment of approximately JPY 15.9 million (USD 0.1 million1) for a drug discovery project for Chagas disease and leishmaniasis.2 

Investment of approximately JPY 679 million (USD 4.5 million1) for the development of diagnostics for tuberculosis
Tuberculosis (TB) remains a serious infectious disease, with approximately 10.8 million cases and 1.25 million deaths reported in 2023, making it the leading causes of death from a single infectious agent.3 The United Nations’ Sustainable Development Goals (SDGs) set a target to end TB by 2030, but achieving this goal requires accurate and accessible diagnostic technologies. Current TB tests face challenges such as low sensitivity, high costs, complexity, and the need for specialized equipment and sputum samples, making them unsuitable for all patients. In particular, children, people with conditions who cannot produce sputum, and those in resource-limited settings often struggle to receive timely diagnoses, causing the continued spread of the disease. To address this issue, the GHIT Fund has decided to invest approximately JPY 679 million (USD 4.5 million1) towards a new TB diagnostic development project by US-based diagnostic developer Fluxus, Inc., 4 in partnership with Fujirebio, Inc., a developer of clinical diagnostics in Japan,4 and Heidelberg University Hospital in Germany.

This project will leverage Fluxus’ cutting-edge ultrasensitive detection technology to develop and validate a urine-based TB biomarker lipoarabinomannan (LAM) assay on its automated benchtop immunoassay analyzer. Additionally, the project will design and develop critical components for a portable, ultrasensitive point-of-care (PoC) system that integrates the urine LAM test. This advanced technology will enable rapid, accurate, and accessible diagnosis across a broader patient population, contributing to improved clinical outcomes and reduced transmission.

In addition, the GHIT Fund will invest approximately JPY 15.9 million (USD 0.1 million1) in a screening project against Chagas disease and leishmaniasis by Kitasato University, Nagasaki University, University of Tokyo, and Drugs for Neglected Diseases initiative (DNDi).

Please refer to Appendix 1 for detailed descriptions on these projects and their development stages.

As of March 31, 2025, the GHIT Fund has invested in 36 projects, including 15 discovery projects, 12 preclinical projects, and 9 clinical trials.5 The total amount of investments since 2013 is JPY 38.2 billion (USD 255 million1) (Appendix 2).

1 USD1 = JPY149.53, the approximate exchange rate on March 31, 2025.
2 These awarded projects were selected and approved as new investments from among proposals to RFP2023-002 and RFP2024-001 for the Product Development Platform and the Screening Platform, which were open for applications from June 2023 to July 2024.
3 WHO: https://www.who.int/news-room/fact-sheets/detail/tuberculosis
4
 Fluxus, Inc. and Fujirebio, Inc. are members of Fujirebio.
5 This number includes projects in the registration phase.

The GHIT Fund is a Japan-based international public-private partnership (PPP) fund that was formed between the Government of Japan, multiple pharmaceutical companies, the Gates Foundation, Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which afflict the world’s vulnerable and underserved populations. In collaboration with global partners, the GHIT Fund mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases.
https://www.ghitfund.org/en

Appendix 1. Project Details

ID: G2023-204

Project Title

Ultrasensitive Detection of Urine LAM for Point-of-Care Rapid Diagnosis of All Forms
of Tuberculosis

Collaboration

Partners

1. Fluxus, Inc. (USA)

2. Fujirebio, Inc. (Japan)

3. Heidelberg University Hospital (Germany)

Disease

Tuberculosis

Intervention

Diagnostics

Stage

Product Design, Product development

Awarded Amount

JPY 679,783,110 (USD 4.54 million)

Status

New project

Summary

[Project objective]

To develop a prototype portable point-of-care (PoC) system and integrated ultrasensitive
assay for detection of Lipoarabinomannan (LAM) in urine. The test will be benchmarked
to a fully-validated ultrasensitive urine LAM assay being developed on Fluxus’
automated benchtop immunoassay analyzer.

 

[Project design]The project objectives will be achieved by performing the following Specific Aims: 1)
Complete development and validation of an ultrasensitive urine LAM assay on an
existing benchtop immunoassay analyzer. This essay will be adapted and transferred to a
stable and cost-effective PoC cartridge format. 2) Design and development of critical
components for a portable, ultrasensitive PoC system, with functional cartridge and prototype PoC LAM assay.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/240/en

ID: S2024-122

Project Title

Searching for Chagas disease therapeutic seed compounds from microbial cultures

Collaboration

Partners

1. Kitasato University (Japan)

2. Nagasaki University (Japan)

3. University of Tokyo (Japan)

4. Drugs for Neglected Diseases initiative (DNDi) (Switzerland)

Disease

Chagas disease / Leishmaniasis

Intervention

Drug

Stage

Screening

Awarded Amount

JPY 15,945,864 (USD 106,639)

Status

New project

Summary

[Project objective]

The main objective of our proposed project is to identify novel T. cruzi active scaffolds
meeting GHIT/DNDi hit criteria and amenable for further development by screening
microbial cultured broths with a natural product chemistry approach. We aim at
characterizing at least five T. new chemical templates unprecedently associated with T.
cruzi
activity over an 18-month work period. We will also opportunistically evaluate the
anti-Leishmania donovani activity of any antichagasic agent to be identified in the course
of the project.

 

[Project design]In this project, three academic institutions (Kitasato University, Nagasaki University, and
the University of Tokyo) and DNDi will utilize their expertise to identify at least five
seed compounds for Chagas disease therapeutics produced by microorganisms in a one-
and-a-half-year research period. The seed compounds for Chagas disease therapeutics to
be identified during the project will also be assessed for their activity against Leishmania
donovani
, which causes visceral leishmaniasis, to verify their drug potential.

Project Detail

https://www.ghitfund.org/investment/portfoliodetail/detail/241/en

*All amounts are listed at an exchange rate of USD1 = JPY149.53, the approximate exchange rate on March 31, 2025.

Appendix 2. Investment Overview (as of March 31, 2025)

Investments to date
Total investments: 38.2 billion yen (USD 255 million1)
Total invested projects: 136 (36 active projects and 100 completed projects)

To learn more about the GHIT Fund’s investments, please visit
Investment Overview: https://www.ghitfund.org/investment/overview/en
Portfolio: https://www.ghitfund.org/investment/portfolio/en
Advancing Portfolio: https://www.ghitfund.org/investment/advancingportfolio/en
Clinical Candidates: https://www.ghitfund.org/investment/clinicalcandidates/en 

For more information, contact:
Katy Lenard at +1-301-280-5719 or klenard@burness.com
Mina Ohata at +81-36441-2032 or mina.ohata@ghitfund.org